186 related articles for article (PubMed ID: 11737591)
1. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane.
Richards HB; Satoh M; Jennette JC; Croker BP; Yoshida H; Reeves WH
Kidney Int; 2001 Dec; 60(6):2173-80. PubMed ID: 11737591
[TBL] [Abstract][Full Text] [Related]
2. Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus.
Calvani N; Satoh M; Croker BP; Reeves WH; Richards HB
Kidney Int; 2003 Sep; 64(3):897-905. PubMed ID: 12911539
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus.
Richards HB; Satoh M; Shaw M; Libert C; Poli V; Reeves WH
J Exp Med; 1998 Sep; 188(5):985-90. PubMed ID: 9730900
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH
J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434
[TBL] [Abstract][Full Text] [Related]
5. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
Clynes R; Calvani N; Croker BP; Richards HB
Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187
[TBL] [Abstract][Full Text] [Related]
7. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
[TBL] [Abstract][Full Text] [Related]
8. Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.
Yoshida H; Satoh M; Behney KM; Lee CG; Richards HB; Shaheen VM; Yang JQ; Singh RR; Reeves WH
Arthritis Rheum; 2002 Aug; 46(8):2235-44. PubMed ID: 12209530
[TBL] [Abstract][Full Text] [Related]
9. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
[TBL] [Abstract][Full Text] [Related]
10. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
12. Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus.
Hamilton KJ; Satoh M; Swartz J; Richards HB; Reeves WH
Clin Immunol Immunopathol; 1998 Mar; 86(3):271-9. PubMed ID: 9557160
[TBL] [Abstract][Full Text] [Related]
13. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
Satoh M; Mizutani A; Behney KM; Kuroda Y; Akaogi J; Yoshida H; Nacionales DC; Hirakata M; Ono N; Reeves WH
Int Immunol; 2003 Sep; 15(9):1117-24. PubMed ID: 12917264
[TBL] [Abstract][Full Text] [Related]
14. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
15. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
16. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
Satoh M; Kumar A; Kanwar YS; Reeves WH
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10934-8. PubMed ID: 7479913
[TBL] [Abstract][Full Text] [Related]
17. Distinctive patterns of autoimmune response induced by different types of mineral oil.
Kuroda Y; Akaogi J; Nacionales DC; Wasdo SC; Szabo NJ; Reeves WH; Satoh M
Toxicol Sci; 2004 Apr; 78(2):222-8. PubMed ID: 14718649
[TBL] [Abstract][Full Text] [Related]
18. Induction of systemic lupus erythematosus syndrome in BALB/c mice by immunization with active chromatin.
Li H; Zhang YY; Sun YN; Huang XY; Jia YF; Li D
Acta Pharmacol Sin; 2004 Jun; 25(6):807-11. PubMed ID: 15169636
[TBL] [Abstract][Full Text] [Related]
19. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane.
Satoh M; Richards HB; Shaheen VM; Yoshida H; Shaw M; Naim JO; Wooley PH; Reeves WH
Clin Exp Immunol; 2000 Aug; 121(2):399-405. PubMed ID: 10931159
[TBL] [Abstract][Full Text] [Related]
20. Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody.
Ravirajan CT; Wang Y; Matis LA; Papadaki L; Griffiths MH; Latchman DS; Isenberg DA
Rheumatology (Oxford); 2004 Apr; 43(4):442-7. PubMed ID: 15024133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
